Literature DB >> 11579950

An inferior mesenteric-caval shunt via the internal iliac vein with portosystemic encephalopathy.

M Otake1, Y Kobayashi, D Hashimoto, T Igarashi, M Takahashi, H Kumaoka, M Takagi, K Kawamura, S Koide, Y Sasada, F Kageyama, T Kawasaki, H Nakamura.   

Abstract

We report here a case of an unusual extrahepatic portosystemic venous shunt in a 37-year-old woman without liver cirrhosis or portal hypertension, who developed portal systemic encephalopathy. Angiography demonstrated an inferior mesenteric-caval shunt characterized by the presence of direct communication of the inferior mesenteric vein with the left internal iliac vein. After the treatment with percutaneous transcatheter embolization of the shunt via a femoral vein approach using coils, she had no episode of portal systemic encephalopathy.

Entities:  

Mesh:

Year:  2001        PMID: 11579950     DOI: 10.2169/internalmedicine.40.887

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  10 in total

1.  Relationship between encephalopathy and portal vein-vena cava shunt: value of computed tomography during arterial portography.

Authors:  Qian Chu; Zhen Li; Su-Ming Zhang; Dao-Yu Hu; Ming Xiao
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

2.  Diagnostic value of 16 slices spiral-CT for portal vein disorders.

Authors:  Zhen Li; Daoyu Hu; Ming Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Successful portal-systemic shunt occlusion of a direct shunt between the inferior mesenteric vein and inferior vena cava with balloon-occluded retrograde transvenous obliteration following recanalization after placing a covered stent in the portal and superior mesenteric veins.

Authors:  Sadao Hayashi; Yasutaka Baba; Terutoshi Senokuchi; Kazuto Ueno; Masayuki Nakajo
Journal:  Jpn J Radiol       Date:  2009-06-06       Impact factor: 2.374

4.  Portosystemic encephalopathy due to mesoiliac shunt in a patient without cirrhosis.

Authors:  Sobia Ali; Alan H Stolpen; Warren N Schmidt
Journal:  J Clin Gastroenterol       Date:  2010 May-Jun       Impact factor: 3.062

Review 5.  Insight into congenital absence of the portal vein: is it rare?

Authors:  Guo-Hua Hu; Lai-Gen Shen; Jin Yang; Jin-Hua Mei; Yue-Feng Zhu
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

6.  Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.

Authors:  Massimiliano Allegritti; Benedetta Enrico; Emanuela Basile; Lara de Vito; Antonino Morabito; Roberto Cirocchi; Michela Giustozzi; Giovanni Passalacqua
Journal:  Dig Dis Sci       Date:  2020-04       Impact factor: 3.199

7.  Noncirrhotic Extrahepatic Portosystemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.

Authors:  Eldad Elnekave; Eugenia Belenky; Lindsley Van der Veer
Journal:  Case Rep Radiol       Date:  2015-06-25

8.  Disabling portosystemic encephalopathy in a non-cirrhotic patient: Successful endovascular treatment of a giant inferior mesenteric-caval shunt via the left internal iliac vein.

Authors:  Luca de Martinis; Gloria Groppelli; Riccardo Corti; Lorenzo Paolo Moramarco; Pietro Quaretti; Pasquale De Cata; Mario Rotondi; Luca Chiovato
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

9.  Recommendation of Repeated Ammonia Tests for Intrahepatic Portal-Systemic Shunt Without Cirrhosis in Elderly Patients With Psychiatric Symptoms.

Authors:  Michiaki Abe; Temma Soga; Nobuya Obana; Kazumasa Seiji; Masao Tabata; Natsumi Saito; Ryutaro Arita; Takehiro Numata; Junichi Tanaka; Hitoshi Kuroda; Shin Takayama; Yutaka Kagaya; Tadashi Ishii
Journal:  Jpn Clin Med       Date:  2017-03-16

Review 10.  Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management.

Authors:  Stefania Gioia; Silvia Nardelli; Oliviero Riggio; Jessica Faccioli; Lorenzo Ridola
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.